Navigation path
2002 Projects
List of projects started in 2002 (sorted by Acronym)
| AFTBVAC | Development of a Tuberculosis Vaccine in Africa |
| AMVTN/AMANET | African Malaria Vaccine Testing Network |
| Bridging gaps | Bridging the Gaps Between Public and Traditional Healthcare Sectors – Testing a Model to Improve Quality of STI/HIV/AIDS Care in sub-Saharan Africa |
| CASA | Optimising the Use of the Syndromic Approach for STI Management and Prevention in Resource Poor Settings |
| CASCADE Virology | Virological Characterisation of Primary HIV Infection in the Concerted Action on SeroConversion to AIDS and Death in Europe |
| China-HIV-VacIII | Phase I/II clinical testing of Clade C-based HIV-1 Candidate Vaccines in China |
| COCONUTKIT | Project to coordinate the write up of a protocol for a clinical trial aimed at shortening treatment for tuberculosis |
| CTL and HIV- super Infection | CTL-Mediated Protection from HIV-1 Infection in a High-Risk Cohort in Tanzania: Persistent Seronegativity, Persistent Single-Subtype Infection, and Cross-Subtype Superinfection |
| EDCTP | European and Developing Countries Clinical Trials Programme |
| EMLI | Phase-I and II Trials of the Malaria Pre-Erythrocytic Vaccine LSA-3 and Refinement of Measurable Outcomes |
| EMVI | European Malaria Vaccine Initiative |
| EUROMALVAC-2 | The Second Phase of a European Malaria Vaccine Development Consortium |
| EuroVac-III | European Vaccine Effort Against HIV/AIDS – III |
| FACT | Development of Oral Fixed Dose Artesunate-Based Combinations for the Treatment of Uncomplicated Malaria |
| HIVIS | Study of Immunogenicity of DNA HIV-1 env, gag and pol Plasmid Vaccines Boosted with MVA in Tanzania: HIV Vaccine Immunogenicity Study |
| HIVPRIMEBOOST THERVAC | Improvement of a Therapeutic Adjuvanted Protein HIV Vaccine by Combination with DNA Immunisation in a Prime-Boost Regimen |
| LAMNET | New Approaches to Improve Coverage and Compliance of Antimalarial Treatment for Pregnant Women in Rural Africa |
| LONG-DRUG | Characterisation of Mycobacterium Tuberculosis Populations During Infection: A Longitudinal Study on Drug Resistance Development |
| MALCROSS | Genetic Analysis of the Chloroquine Drug Resistance and the Accelerated-Resistance-to Multiple Drugs Phenotypes in the Human Malarial Parasite Plasmodium Falciparum |
| MALVECASIA | Monitoring Insecticide Resistance and Mapping Malaria Vectors in Southeast Asia : A Prerequisite for Sustainable Malaria Vector Control |
| MAMOP | Improving the Management of Childhood Malaria: An Experiment to Bridge the Gap Between Mothers and Healthcare Providers |
| MICROBICIDES 2002 | Conference ‘Microbicides 2002’ Antwerp, 12-15 May 2002 |
| MUVADEN | Mucosal Vaccines Against Human and Simian Immunodeficiency Viruses Based on Dendritic Cells |
| NEW ANTIMALARIALS | Clinical and Pre-Clinical Evaluation of Fosmidomycin and its Derivates as Antimalarial Drugs |
| NEW ANTIMYCOBACTERIALS | Inhibitors of the Nonmevalonate Pathway of Isoprenoid Biosynthesis as Drugs Against Tuberculosis |
| New cAMP antagonists | Development of Antagonists that Disrupt the Hyperactivated cAMP Signalling Pathway in Immunodeficiencies as Immunostimulatory Therapy |
| PERSISTENT TB | Novel Drug Targets Specific to Persistent (Latent) Tuberculosis Infection: Crystallisation, Structure Determination and Functional Studies |
| SATZ | Promoting Sexual and Reproductive Health. School-Based HIV/AIDS Prevention in Sub-Saharan Africa |
| SPREAD | Strategy to Control SPREAD of HIV Drug Resistance |
| THERAVAC | Evaluation of a Therapeutic Vaccination Strategy for HIV-1 Infection TheraVac |
| Upgrade Diagno MDR-TB | Improved Diagnosis, Drug Resistance Detection and Control of Tuberculosis in Latin America |
| VIRIMAL | Structure, Function and Vaccine Potential of the Vir Multigene Family in Malaria |
| VIRULENCE | HIV-1 Reverse Transcriptase Inhibitor Resistance and Its Consequences for Viral Virulence |
| X-TB | Structural and Functional Genomics of Mycobacterium Tuberculosis |